Primrose Bio develops new manufacturing solutions for next generation therapeutics and vaccines. Primrose’s major offerings include Pfenex Expression Technology®, a Pseudomonas fluorescens-based protein expression platform; Prima RNApols™, superior RNA polymerases for mRNA manufacturing; and PeliCRM197®, a commercially validated carrier protein for conjugate vaccines. Leading pharmaceutical companies, including Merck, Jazz Pharmaceuticals, and Serum Institute of India, use Primrose’s technologies. Visit: www.primrosebio.com.